Sleeve Gastroplasty Combined with the NLRP3 Inflammasome Inhibitor CY-09 Reduces Body Weight, Improves Insulin Resistance and Alleviates Hepatic Steatosis in Mouse Model

ConclusionsSurgery imitating ESG combined with CY-09 reduces body weight, improves insulin resistance and alleviates hepatic steatosis. The combination therapy may be a promising method for treating obesity and NAFLD.

http://link.springer.com/10.1007/s11695-020-04571-8

Source: Obesity Surgery - April 7, 2020 Category: Surgery Source Type: research